Reference : In Vitro Cytotoxic Activity of Two Potential Anticancer Drugs Isolated from Strychnos: S...
Scientific journals : Article
Human health sciences : Pharmacy, pharmacology & toxicology
http://hdl.handle.net/2268/39255
In Vitro Cytotoxic Activity of Two Potential Anticancer Drugs Isolated from Strychnos: Strychnopentamine and Usambarensine
English
Bonjean, K. A. [> > > >]
Gillet, Marie-Claire mailto [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Histologie - Cytologie - Département des sciences biomédicales et précliniques >]
Quetin-Leclercq, J. [> > > >]
Angenot, Luc mailto [Université de Liège - ULg > Département de pharmacie > Pharmacognosie >]
Bassleer, R. J. [> > > >]
1996
Anticancer Research
16
3A, May-Jun
1129-37
Yes (verified by ORBi)
International
0250-7005
[en] strychnopentamine ; usambarensine ; B16 melanoma cells ; cytotoxicity ; RNA synthesis ; hemolysis
[en] The cytotoxicity and the selective antiprotozoal activity of some Strychnos alkaloids, namely strychnopentamine (SP) and usambarensine (US) (7) led us to analyze and compare their effects with emetine (EM) by using mouse B16 melanoma cells cultivated in vitro. We observed by cytological analysis and proliferation rate studies that these substances induce analogous cytotoxic effects in B16 cells, but at different concentrations i.e. formation of lamellar bodies in the cytoplasm, the which contain pre-melanosomes in the case of SP and US, vacuoles and blebs. At concentrations near their respective IC50, SP and US, but not EM, decreased colony formation. We showed by incorporation of labelled precursors that SP and US first inhibit RNA synthesis while EM initially acts on protein synthesis. These alkaloids increased melanin synthesis. Furthermore, only EM and SP caused hemolysis of sheep red blood corpuscles. This could explain why the rate of antiplasmodial activity is higher for SP and EM.
http://hdl.handle.net/2268/39255

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Anticancer Research 16 (1996) pp 1129_1138.pdfPublisher postprint641.78 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.